Succinic Acid

Succinic Acid

SCHEMBL3830489

COc1cc(C(F)(F)F)cc(C(F)(F)F)c1C(=O)NC(c1ccccc1)C(C)(C)N1CCCC1.O=C(O)CCC(=O)O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 11/20 0.49
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
SLC6A5 Q9Y345 1/20 0.38
TACR1 P25103 1/20 0.38
MTTP P55157 4/20 0.38
TRPV4 Q9HBA0 1/20 0.37
S1PR1 P21453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL3836544 1.00 SLC6A9 (0.49) SLC6A9CYP2D6CYP2C19SLC6A5TACR1
Succinic Acid SCHEMBL3831049 1.00 SLC6A9 (0.49) SLC6A9CYP2D6CYP2C19SLC6A5TACR1
SCHEMBL3014546 0.96 SLC6A9 (0.52) SLC6A9CYP2D6CYP2C19SLC6A5TACR1
SCHEMBL3832646 0.96 SLC6A9 (0.52) SLC6A9CYP2D6CYP2C19SLC6A5TACR1
SCHEMBL3008740 0.96 SLC6A9 (0.52) SLC6A9CYP2D6CYP2C19SLC6A5TACR1
SCHEMBL29765315 0.96 SLC6A9 (0.52) SLC6A9CYP2D6CYP2C19SLC6A5TACR1
SCHEMBL3239910 0.95 SLC6A9 (0.51) SLC6A9CYP2D6CYP2C19SLC6A5TACR1
SCHEMBL3243383 0.95 SLC6A9 (0.51) SLC6A9CYP2D6CYP2C19SLC6A5TACR1
Hydrochloric Acid SCHEMBL3243468 0.95 SLC6A9 (0.51) SLC6A9CYP2D6CYP2C19SLC6A5TACR1
SCHEMBL3238676 0.88 SLC6A9 (0.44) SLC6A9TACR1TRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2041082-B1 PYRROLIDINE DERIVATIVES HAVING ACTIVITY AT THE GLYT1 TRANSPORTER GLAXO GROUP LTD (GB) 2009-09-30 EP claimed
US-20080070973-A1 Compounds having activity at the GlyT1 transporter GLAXO GROUP LIMITED (GB) 2008-03-20 US claimed
EP-2041082-B1 PYRROLIDINE DERIVATIVES HAVING ACTIVITY AT THE GLYT1 TRANSPORTER GLAXO GROUP LTD (GB) 2009-09-30 EP disclosed
EP-2041082-A1 PYRROLIDINE DERIVATIVES HAVING ACTIVITY AT THE GLYT1 TRANSPORTER Glaxo Group Limited (GB) 2009-04-01 EP disclosed
US-20080070973-A1 Compounds having activity at the GlyT1 transporter GLAXO GROUP LIMITED (GB) 2008-03-20 US disclosed
WO-2007147831-A1 PYRROLIDINE DERIVATIVES HAVING ACTIVITY AT THE GLYT1 TRANSPORTER GLAXO GROUP LIMITED (GB) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070973-A1 Compounds having activity at the GlyT1 transporter SLC6A7, SLC6A1, SLC6A4 SLC6A9 27/4885CYP2D6 311/4885CYP2C19 785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.